Raymond Myers analyst

Currently out of the existing stock ratings of Raymond Myers, 7 are a BUY (70%), 3 are a HOLD (30%).

Raymond Myers

Work Performance Price Targets & Ratings Chart

Analyst Raymond Myers, currently employed carries an average stock price target met ratio of 100% that have a potential upside of 29.03% achieved within 205 days. Previously, Raymond Myers worked at BENCHMARK.

Raymond Myers’s has documented 24 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on HSKA, Heska at 07-May-2018.

Wall Street Analyst Raymond Myers

Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 10/31/2017. The price target of $60 was fulfilled within 7 days with a profit of $5.01 (9.11%) receiving and performance score of 13.02.

Average potential price target upside

EXAS EXACT Sciences HSKA Heska LMAT LeMaitre Vascular NVTA Invitae Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$75

$25.67 (52.04%)

$85

10 days ago
(11-Nov-2024)

4/9 (44.44%)

$23.67 (46.11%)

31

Buy

$65

$15.67 (31.77%)

$67

15 days ago
(06-Nov-2024)

10/12 (83.33%)

$14.51 (28.74%)

151

Buy

$67

$17.67 (35.82%)

$75

15 days ago
(06-Nov-2024)

9/10 (90%)

$16.51 (32.70%)

77

Buy

$65

$15.67 (31.77%)

$75

15 days ago
(06-Nov-2024)

0/5 (0%)

$14.51 (28.74%)

Buy

$75

$25.67 (52.04%)

$95

15 days ago
(06-Nov-2024)

2/11 (18.18%)

$24.51 (48.54%)

39

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Raymond Myers?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?